Case Report
In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways
Table 2
Summary of amino acid changes in C/T-resistant compared to C/T-susceptible P. aeruginosa.
| Strain | Predicted gene product | Predicted amino acid change | Comments |
| PA2428a | AmpD | Val10 ⟶ Gly | N-Acetylmuramoyl-L-alanine amidase | AmpC | Val213 ⟶ Ala | β-Lactamase | DacB | Gly87 ⟶ Asp | D-Alanyl-D-alanine carboxypeptidase |
| HOU2366b | MexR | Lys67 ⟶ Glu | Transcriptional regulator | AmpC | Δ21 bp 210-216 | β-Lactamase | DUF | Asp265 ⟶ Ala | Predicted signal transduction protein | PuuA | Leu236 ⟶ Pro | Gamma-glutamyl-putrescine synthetase |
|
|
aCompared to C/T-susceptible PA2312; bcompared to C/T-susceptible HOU2365.
|